VCLNSEVaxtex Cotfab LimitedLowNeutral
Announced Fri, 27 Feb · 18:20 IST

Vaxtex Cotfab Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 27, 2026

Board & Shareholder Meetings View source PDF

VCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vaxtex Cotfab Limited held an Extra-Ordinary General Meeting on February 27, 2026 via video conferencing, lasting about 24 minutes (4:00 PM to 4:24 PM). The meeting considered 10 special business items, including a proposal to increase the company's authorised share capital, alter the object clause of the Memorandum of Association, and change the company's name along with other clauses in the MoA and Articles of Association. Other key items included raising borrowing limits under Section 180(1)(C) of the Companies Act, expanding the company's ability to give loans, guarantees and make investments beyond Section 186 limits, and regularising the appointments of five directors (one Executive, one Whole-Time, and three Independent Directors). The e-voting window ran from February 24 to February 27, 2026, with G Aakash & Associates acting as Scrutinizer. Voting results are awaited and will be shared with the exchange in due course.

Likely market impact

Shareholders should watch for the voting results, as passing these resolutions could enable the company to raise fresh capital, take on more debt, diversify its business, and even rebrand through a name change — all of which could materially affect the stock's direction. Director regularisations also suggest governance housekeeping, possibly tied to a broader corporate restructuring.